In connection with the acquisition of NASDAQ-listed biopharmaceutical company The Medicines Company for USD 9.7 billion, Novartis AG and Novartis Finance Corporation entered into a USD 7 billion short-term (bridge) credit agreement and completed a USD 5 billion four-tranche SEC-registered bond offering. Bär & Karrer acted as Swiss legal advisor to Novartis in this transaction.
EQT portfolio company Open Systems AG, a secure access service edge (SASE) pioneer, has acquired Sqooba (Schweiz) AG from its founders. Sqooba is a Swiss-based leader in big data analytics.
La Mobilière acquires a stake of 25% of the shares in Ringier AG. The share purchase is to be completed in the first half of 2020.
Migros-Genossenschafts-Bund (MGB) sold Magazine zum Globus AG along with eight associated real estate properties to a joint venture of SIGNA and CENTRAL Group. SIGNA and CENTRAL jointly own Germany’s KaDeWe Group and CENTRAL Group currently owns Italy’s Rinascente and Denmark’s Illum, all leading luxury department stores in Europe. The transaction is subject to approval by …
The von Finck family successfully placed 960,000 shares (approx. 12.7%) in SGS SA by way of an accelerated bookbuilding process. The overall transaction volume amounts to CHF 2.3 billion. In light of its long-term investment strategy and planning, the family decided to divest a majority of its stake in SGS.
Waters Corporation, a leading specialty measurement company, has announced the acquisition of Andrew Alliance, a Switzerland based company specializing in laboratory automation technology.
DHL Logistics (Schweiz) AG sold its Swiss supply chain business to Fastlog AG, a Swiss service and logistics provider.
Polhem Infra, a company formed in 2019 by the First, Third and Fourth AP Fund (Swedish National Pension Funds), acquired 21 per cent of the shares in Solör Bioenergi Holding from existing shareholders. Solör Bioenergy is a leading provider of renewable energy based on wood fuel and district heating in Sweden and Norway.
Ardian and other sellers agreed to sell the Competence Call Center Group to TELUS International.
Pharmalys Invest Holding AG, which is controlled by Amir Mechria, owned49% of Pharmalys Laboratories SA, Pharmalys Africa Sarl and Pharmalys TunisiaSA and has now purchased the remaining 51% of the shares in these companiesfrom Hochdorf Holding AG.